TARGET E*STUDIO
LIVE

Serial Number

86397158

Owner

TARGET HEALTH, LLC

Attorney

Kenneth I. Kohn

First Use Date

Jul 7, 2011

Filing Date

Sep 17, 2014

Add to watchlist:

No watchlists yet
View on USPTO

TARGET E*STUDIO Trademark

Serial Number: 86397158 • Registration: 4879468

TARGET E*STUDIO is a trademark filed by TARGET HEALTH, LLC on September 17, 2014. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

TARGET HEALTH, LLC (10 trademarks)

261 MADISON AVENUE
NEW YORK, NY 10016

Entity Type: 16

Target Health, Inc. (22 trademarks)

305 Madison Avenue, Suite 2501
New York, NY 10165

Entity Type: 11

Trademark Details

Filing Date

September 17, 2014

Registration Date

January 5, 2016

First Use Anywhere

July 7, 2011

First Use in Commerce

July 7, 2011

Published for Opposition

October 20, 2015

Goods & Services

Providing a website featuring non-downloadable software for use in gathering and providing clinical trial data regarding medical and scientific research; Scientific research; Technical consultation and research in the medical and pharmaceutical fields; Product research and development; medical and scientific research services in the field of treatment and diagnosis provided for medical service providers; Technical writing for others; Providing quality assurance services in the field of pharmaceuticals; troubleshooting of product and process development problems dealing with safety and regulatory toxicology programs as it relates to medical and scientific research in the development of pharmaceutical drugs; Medical and scientific research, namely, conducting clinical trials; Consultation in the fields of pharmaceutical drug development, conducting clinical trials; consultation in the field of pharmaceuticals drug development, namely, consulting with sponsor, medical, scientific, toxicology, manufacturing and business experts to clearly delineate development requirements and evaluate available and competitive technologies; development of pharmaceutical product processes for others; Technical writing for others, namely, writing integrated clinical and statistical study reports and regulatory manuscripts relating to medical and scientific research in the development of pharmaceutical drugs, as an integrated component; compiling patient records and patient data via a global computer information network for research purposes in the fields of medical science and medical consultancy

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 5, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 28, 2021 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 28, 2021 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 27, 2021 APRE
TEAS SECTION 8 & 15 RECEIVED
May 7, 2021 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 5, 2021 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 12, 2020 ASGN
REGISTERED-PRINCIPAL REGISTER
Jan 5, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2015 NPUB
PUBLISHED FOR OPPOSITION
Oct 20, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 30, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 14, 2015 PREV
ASSIGNED TO LIE
Sep 13, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 15, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 14, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 14, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jan 14, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jan 14, 2015 CNRT
ASSIGNED TO EXAMINER
Dec 31, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 24, 2014 NWOS
NEW APPLICATION ENTERED
Sep 20, 2014 NWAP